Stemler, Jannik http://orcid.org/0000-0001-9152-2469
Koehler, Philipp http://orcid.org/0000-0002-7386-7495
Maurer, Christian http://orcid.org/0000-0003-4388-5163
Müller, Carsten http://orcid.org/0000-0002-2861-9185
Cornely, Oliver A. http://orcid.org/0000-0001-9599-3137
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 7 April 2020
Accepted: 27 May 2020
First Online: 8 June 2020
Compliance with ethical standards
:
: JS reports research grants from Basilea Pharmaceutica International Ltd. and travel grants from Meta-Alexander Foundation and from the German Society for Infectious Diseases (DGI) outside of the submitted work.PK has received non-financial scientific grants from Miltenyi Biotec GmbH, Bergisch Gladbach, Germany, and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany, and received lecture honoraria from Akademie für Infektionsmedizin e.V., Astellas Pharma, Gilead Sciences, GPR Academy Ruesselsheim, MSD Sharp & Dohme GmbH, and University Hospital, LMU Munich outside the submitted work.ChM reports travel grants from Munipharma, Amgen, Servier Deutschland GmbH.CaM reports no conflict of interest.OAC has received research grants from Actelion, Amplyx, Astellas, Basilea, Cidara, Da Volterra, F2G, Gilead, Janssen Pharmaceuticals, Medicines Company, MedPace, Melinta Therapeutics, Merck/MSD, Pfizer, and Scynexis; is a consultant to Actelion, Allecra Therapeutics, Amplyx, Astellas, Basilea, Biosys UK Limited, Cidara, Da Volterra, Entasis, F2G, Gilead, Matinas, MedPace, Menarini Ricerche, Roche Diagnostics, Merck/MSD, Nabriva Therapeutics, Octapharma, Paratek Pharmaceuticals, Pfizer, PSI, Rempex, Scynexis, Seres Therapeutics, Tetraphase, and Vical; and received lecture honoraria from Astellas, Basilea, Gilead, Grupo Biotoscana, Merck/MSD, and Pfizer.